Catecholamines interrelation in plasma of early diagnosed treatment-naive patients with Parkinson disease
Objective: To investigate the interrelation of catecholamines in the blood plasma of healthy people and PD patients. Background: The study “START-1” was funded by Investment…A patient with myotonic dystrophy type 1 and parkinsonism
Objective: We report the first case of myotonic dystrophy (DM) type 1 with DMPK mutations presenting with parkinsonian syndrome. Background: DM type 1 is a…Prevalence and risk factor of peak-dose dyskinesia in Thai patients with Parkinson’s disease
Objective: To determine the prevalence and risk factors associated with peak-dose dyskinesia in Thai patients with Parkinson’s disease. Background: Dyskinesias are involuntary movement that interfere…Suicide attempts, suicidal and death ideation in Parkinson’s disease
Objective: The objective of this study was to assess the correlates of suicidal and death ideation and suicide attempts in patients with parkinson’s disease. Background:…Prevalence and risk factors for visual hallucinations in Chinese patients with Parkinson’s disease
Objective: The aim of this study was to illuminate the prevalence and clinical correlates of VHs in the Chinese population with PD. Background: Parkinson's disease…Missing Data in the Unified Dyskinesia Rating Scale (UDysRS)
Objective: Identify the number of allowable missing values still permitting valid surrogate score calculation for the Unified Dyskinesia Rating Scale (UDysRS). Background: Missing data occur…Preliminary Results of Psychometric Properties of the Turkish version of Falls Efficacy Scale – International in Patients with Parkinson’s Disease
Objective: To assess the psychometric properties of the Turkish version of Falls Efficacy Scale - International (FES-I) in Parkinson’s disease (PD) patients. Background: Fear of…Zonisamide improves parkinsonism in DLB patients: A randomized phase 3 trial
Objective: To verify the efficacy and safety of zonisamide (ZNS) for parkinsonism in patients with dementia with Lewy bodies (DLB). Background: DLB parkinsonism is responsive…A case of early onset parkinsonism caused by PLA2G6 gene mutation
Objective: To report and follow up a case of early-onset parkinsonism (EOP) caused by mutation of PLA2G6 gene and to improve the understanding and treatment…Brief Cognitive Screening for Parkinson’s disease by the Korean Version of the Montreal Cognitive Assessment
Objective: We evaluated the screening ability of the Korean version of the Montreal Cognitive Assessment (K-MoCA) in the patients with Parkinson's disease. Background: The Montreal…
- « Previous Page
- 1
- …
- 39
- 40
- 41
- 42
- 43
- …
- 177
- Next Page »